Altman Advisors, Inc. Amgen Inc Transaction History

Altman Advisors, Inc.

$224 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $2.5 Million - $2.93 Million	-11,785 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $133,140 - $147,709	570 Added 5.08%	11,785 $2.69 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $86,544 - $100,854	-390 Reduced 3.36%	11,215 $2.79 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $1,081 - $1,288	-5 Reduced 0.04%	11,605 $2.67 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $10,324 - $11,481	44 Added 0.38%	11,610 $2.95 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $50,837 - $62,384	-257 Reduced 2.17%	11,566 $2.73 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $110,255 - $146,228	-605 Reduced 4.87%	11,823 $2.4 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $44,464 - $57,152	-235 Reduced 1.86%	12,428 $3 Million
Q3 2019 Oct 09, 2019	SELL	$174.11 - $208.62 $8,009 - $9,596	-46 Reduced 0.36%	12,663 $2.45 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $39,007 - $45,725	234 Added 1.88%	12,709 $2.34 Million
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $68,911 - $77,678	-381 Reduced 2.96%	12,475 $2.37 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $50,130 - $58,518	281 Added 2.23%	12,856 $2.5 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $782,109 - $881,724	-4,221 Reduced 25.13%	12,575 $2.61 Million
Q2 2018 Aug 02, 2018	BUY	$166.05 - $186.51 $750,878 - $843,398	4,522 Added 36.84%	16,796 $2.42 Million
Q1 2018 Apr 27, 2018	BUY	$169.43 - $198.0 $39,477 - $46,134	233 Added 1.94%	12,274 $2.09 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $2.03 Million - $2.27 Million	12,041	12,041 $2.09 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.

Account